Monogram Orthopaedics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	-13.75	-13.69	-11.81	-9.07	-1.8	-0.71	-0.66
Depreciation & Amortization	0.41	0.39	0.32	0.1	0.03	0.03	0.01
Share-Based Compensation	1.56	0.74	0.21	2.16	0.61	0	0
Other Operating Activities	-1.77	4.14	2.12	1.4	0.1	0.37	0.03
Operating Cash Flow	-13.54	-8.42	-9.17	-5.4	-1.05	-0.31	-0.62
Capital Expenditures	-0.06	-0.24	-0.03	-1.18	-0.01	-0.15	-0.15
Other Investing Activities	-	-	-0.98	-0.15	-	-	-
Investing Cash Flow	-0.06	-0.24	-1.01	-1.33	-0.01	-0.15	-0.15
Share Issuance / Repurchase	15.33	0	0	0	0	0	0
Debt Issued / Paid	0	0	0	-0.76	-0.08	1.15	1
Other Financing Activities	1.4	13.59	10.12	10.77	2.53	-	-
Financing Cash Flow	16.73	13.59	10.12	10.01	2.45	1.15	1.01
Net Cash Flow	3.12	4.93	-0.05	3.27	1.4	0.69	0.24
Free Cash Flow	-13.61	-8.66	-9.2	-6.59	-1.05	-0.46	-0.77
Free Cash Flow Margin	-3728.07%	-	-1464.25%	-	-	-	-
Free Cash Flow Per Share	-0.61	-0.90	-0.95	-0.72	-0.18	-2.23	-4.39

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).